About
Anabella Villalobos is a biopharmaceutical R&D executive and medicinal chemist who currently serves as Chief Scientific Officer of Metaphore Biotechnologies and sits on the board of Coya Therapeutics. She previously led Biotherapeutics and Medicinal Sciences at Biogen from 2017 to 2025 after a 28-year career at Pfizer. Her work has focused on neuroscience, rare disease, autoimmune disease, gene therapy, and broader drug-discovery strategy.
Areas of interest
biotechdrug discoverymedicinal chemistryneuroscienceneurodegenerative diseaserare diseaseautoimmune diseasegene therapybiologicsoligonucleotidesAI drug designfunctional antibodiesoncology